MDM2 and neoplasm: The discovery that the small molecule nutlin-3a could bind to MDM2 and release p53 from its inhibition resulting in apoptosis and hindered tumor growth in vivo [132] spurred the development of multiple small molecule drugs that can also inhibit this interaction [133,134,135,136,137].